Work

EE408 Embracing the Long-Term in Disruptive Health Innovations: A Strategic Necessity or a Necessary Evil? Cost Utility of Langerhans Islet Grafting in Unstable Type 1 Diabetes

Year: 2025

Type: conference-abstract

Source: Value in Health

DOI: 10.1016/j.jval.2025.09.791

Authors: Sandra David-Tchouda, Rosy Fares, Hanane Kebaili, Dimitri Sourd, Thierry Berney, Laurence Kessler, Lionel Badet, Jean-Pierre Riveline, François Pattou, Sandrine Lablanche, Pierre-Yves Benhamou

Institutions: Centre Hospitalier Universitaire de Grenoble, University Hospital of Geneva, Centre Hospitalier Universitaire de Saint-Étienne, Assistance Publique – Hôpitaux de Paris, Centre Hospitalier Universitaire de Lille

Language: English

Topic: Health Systems, Economic Evaluations, Quality of Life

Subfield: Economics and Econometrics

Field: Economics, Econometrics and Finance

Domain: Social Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4417480331

Cites:

Cited by: 1

Related to: 10